A Colorado public benefit corporation breached a loan agreement by failing to use the $400,000 loan for its intended purpose and instead diverting the loan to settle a nearly $600,000 civil penalty with a federal governmen...(read more)

Dozens of state attorneys general urged a Connecticut federal judge Tuesday not to let Taro Pharmaceuticals block a swath of their price-fixing claims with a $200 million settlement it struck with plaintiffs in separate mu...(read more)

Dubbed the "Queen of the False Claims Act" by an opposing counsel, Jennifer Weaver of Holland & Knight LLP convinced the government to drop its investigation into California's Cedars-Sinai Medical Center and successfully d...(read more)

CVS Health said Wednesday that it plans to split into two independent, publicly traded companies, separating its Aetna- and Caremark-led healthcare businesses from its 9,000 retail pharmacy locations, reversing its nearly ...(read more)

A Delaware federal judge on Tuesday threw out Mallinckrodt Pharmaceuticals' $9.5 million jury award it won in an infringement case and instead blocked a competitor's inhaled nitric oxide treatment patent until after a pair...(read more)

Cancer drug developer Karyopharm Therapeutics Inc. on Tuesday secured a Texas bankruptcy judge's approval to borrow $25 million in Chapter 11 financing and solicit bids for its business, as the company looks to merge with ...(read more)

U.S. Patent and Trademark Office Director John Squires on Tuesday instituted four inter partes reviews in what could be the final petitions for which he reviews the merits.

A California federal judge certified four classes of Facebook users who allege Meta Platforms collected their personal health information through data tracking tools on healthcare providers' websites, rejecting the social ...(read more)

The lawyers chosen as Law360's 2026 MVPs stand out from their peers by notching significant achievements in high-stakes litigation, complex global matters and record-setting transactions.

A California federal judge said Thursday that he'll give final approval to a $59.5 million settlement resolving class claims over a menstrual tracking app sharing sensitive health data with Google, but he cut the $19 milli...(read more)

U.S. Patent and Trademark Office Director John Squires has greenlighted four new petitions seeking review of patents in his latest round of decisions, while turning down one on discretionary grounds.

Risk management firm Milliman Inc. is set to pay $15.5 million to resolve a consumer class action accusing the company of peddling flawed information to life insurance companies, according to a proposed settlement that the...(read more)

Washington state must pay plaintiffs' counsel roughly $73,000 in attorney fees and costs in a long-running case over its treatment of pretrial detainees in criminal proceedings, a Washington federal judge has ruled.

A New York federal judge gave his blessing Thursday to a $12.9 million deal Anthem struck to resolve a suit claiming the insurance company violated federal benefits law by denying coverage for residential behavioral health...(read more)

Aetna Health Inc. can't force two hospital operators to arbitrate their challenge to its inpatient reimbursement policy, a Pennsylvania federal judge ruled, finding the suit seeks equitable relief and thus falls under an e...(read more)

Two federal employees urged a D.C. federal court to block President Donald Trump's administration from eliminating coverage for gender-affirming care from their 2027 health benefits, arguing thousands of people will be har...(read more)

Albertsons and its Safeway subsidiary must pay $900 million for helping fuel Washington state's overdose crisis by failing for years to prevent the diversion of opioid drugs, a Seattle judge ruled Thursday, finding that th...(read more)

A pharmaceutical industry trade group has backed Bristol-Myers Squibb and its Celgene subsidiary in the Second Circuit, warning that health plans asking the appeals court to reinstate a proposed class action against the co...(read more)